PureTech Health PLCEigentümerstruktur
| Preis (2026-07-17) | 52W Hoch | 52W Tief |
| 17.38 USD | 19,92 USD | 14,5 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 46 USD | 2 | 0 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 24.341.819 | 0,12 | 3,94 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name PureTech Health PLC
Mitarbeiter 56
Handelsplatz NASDAQ
Ticker Symbol PRTC
IPO Datum 2020-11-16
Adresse 6 Tide Street, Boston, MA, United States, 02210
Webseite https://www.puretechhealth.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Robert Lyne J.D., L.L.B. | CEO & Director |
| 2 | Dr. Robert S. Langer Jr., Ph.D., ScD | Co-Founder & Non-Executive Director |
| 3 | Dr. Eric Elenko Ph.D. | Co-Founder & President |
| 4 | Dr. David R. Elmaleh Ph.D. | Co-Founder & Senior Advisor |
| 5 | Ms. Lauren A. White M.B.A. | Chief Financial Officer |
| 6 | Mr. Michael Inbar CPA, M.B.A. | Chief Accounting Officer |
| 7 | Ms. Allison Mead Talbot | Senior VP of Communications & Head of Investor Relations |
| 8 | Mr. Charles Sherwood III, J.D., Ph.D. | General Counsel & Company Secretary |
| 9 | Mr. Spencer Ball | Executive Vice President of Human Resources |
| 10 | Ms. Aleksandra Filipovic M.D., Ph.D. | Head of Oncology |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Pentwater Capital Management LP | 0,00% | 0,00 Mio. USD |
| 2 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 3 | Diadema Partners LP | 0,00% | 0,00 Mio. USD |
| 4 | Persistent Asset Partners Limited | 0,00% | 0,00 Mio. USD |
| 5 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 6 | SBI Securities Co Ltd | 0,00% | 0,00 Mio. USD |